|
|
||||||||
1 School of Rehabilitation Therapy, 2 Department of Physiology, and 3 Department of Surgery, Queen's University, Kingston, Ontario, Canada K7L 3N6
The hemodynamic and
proinflammatory effects of endothelin-1 (ET-1) in proximal (1st/2nd
order) and terminal (3rd/4th order) arterioles and venules were
examined in small intestine submucosa of anesthetized guinea pigs.
Vessel diameter (D), red blood cell velocity, and blood flow (Q) were
determined in eight proximal and eight terminal microvessels before and
at 20 min of ET-1 suffusion (10
10, 10
9, and
10
8 M) and then with endothelin-A
(ETA)-receptor blockade with BQ-123 (10
5 M).
This protocol was repeated with platelet-activating factor (PAF)
inhibition (WEB-2086, 1.0 mg/kg iv; n = 16). The
ET-1-mediated microvascular responses were also examined with
endothelin-B (ETB)-receptor blockade using BQ-788
(10
5 M; n = 11) alone or with
ETA+B-receptor blockade with BQ-123 + BQ-788
(n = 10). Microvascular permeability was assessed by FITC-albumin (25 mg/kg iv) extravasation in seven series: 1)
buffered modified Krebs solution suffusion (n = 6),
2) histamine suffusion (HIS; 10
3 M,
n = 5), 3) ET-1 suffusion (10
8
M, n = 5), 4) BQ-123 (10
5 M)
plus ET-1 suffusion (n = 5), 5) PAF
inhibition before ET-1 suffusion (n = 5), 6)
histamine-1 (H1)-receptor blockade (diphenhydramine, 20 mg/kg iv)
before ET-1 suffusion (n = 5), and 7)
ETB-receptor blockade before (BQ-788 10
5 M;
n = 3) or with ET-1 suffusion (n = 3).
D and Q decreased at 10
8 M ET-1 and returned to control
values with BQ-123 and BQ-123+BQ788 but not with BQ-788 in proximal
microvessels. D did not change in terminal microvessels with ET-1
(10
8 M) but decreased with BQ-788 and increased with
BQ-123. PAF inhibition did not affect the D and Q responses of proximal
microvessels to ET-1 but prevented the fall in Q in terminal
microvessels with ET-1. ET-1 increased vascular permeability to ~1/3
of that with HIS; this response was prevented with BQ-123 and WEB-2086
but not with H1-receptor blockade. This is the first evidence that submucosal terminal microvessel flow is reduced with ET-1 independent of vessel diameter changes and that this response is associated with
increased microvascular permeability mediated via
ETA-receptor stimulation and PAF activation.
blood flow
This article has been cited by other articles:
![]() |
E. Y. Lai, A. E. G. Persson, B. Bodin, O. Kallskog, A. Andersson, U. Pettersson, P. Hansell, and L. Jansson Endothelin-1 and pancreatic islet vasculature: studies in vivo and on isolated, vascularly perfused pancreatic islets Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1616 - E1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Nowicki IL-1beta alters hemodynamics in newborn intestine: role of endothelin Am J Physiol Gastrointest Liver Physiol, September 1, 2006; 291(3): G404 - G413. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |